Knockdown of IRF2 protein with si-IRF2 (but not si-NT negative control) decreased the expression of endogenous IRF2, and likewise decreased the expression of β-catenin in HCC cells (Fig. 2A). The gene discussed is IRF2; the disease is hepatocellular carcinoma.